| Entry |
|
|---|
| Name |
Fostemsavir (USAN) |
|---|
| Abbr |
FTR |
|---|
| Formula |
C25H26N7O8P
|
|---|
| Exact mass |
583.1580
|
|---|
| Mol weight |
583.49
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
Transporter substrate
DG01665 ABCB1 substrate
DG01913 ABCG2 substrate
Transporter inhibitor
DG02862 ABCG2 inhibitor
DG02865 SLCO1B1 inhibitor
DG02907 SLCO1B3 inhibitor
|
|---|
| Remark |
| Product (DG01860): | D10708<US> |
|
|---|
| Efficacy |
Antiviral |
|---|
| Comment |
Active form of prodrug: Temsavir [DR: D10734]
Treatment of HIV
|
|---|
| Target |
|
|---|
| Pathway |
| ko03260 | Virion - Human immunodeficiency virus |
| ko04061 | Viral protein interaction with cytokine and cytokine receptor |
| ko05170 | Human immunodeficiency virus 1 infection |
|
|---|
| Metabolism |
|
|---|
| Interaction |
Transporter inhibition: ABCG2 [HSA: 9429], SLCO1B1 [HSA: 10599], SLCO1B3 [HSA: 28234]
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX29 Fostemsavir
D10707 Fostemsavir (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG01860 Temsavir
D10707 Fostemsavir
Transporter substrate
DG01665 ABCB1 substrate
DG01860 Temsavir
D10707 Fostemsavir
DG01913 ABCG2 substrate
DG01860 Temsavir
D10707 Fostemsavir
Transporter inhibitor
DG02862 ABCG2 inhibitor
DG01860 Temsavir
D10707 Fostemsavir
DG02865 SLCO1B1 inhibitor
DG01860 Temsavir
D10707 Fostemsavir
DG02907 SLCO1B3 inhibitor
DG01860 Temsavir
D10707 Fostemsavir
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
HIV gp41/gp120
D10707 Fostemsavir (USAN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10707
Drug transporters
D10707
Prodrugs [br08324.html]
D10707
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG01860 Temsavir
Transporter substrate
DG01665 ABCB1 substrate
DG01860 Temsavir
DG01913 ABCG2 substrate
DG01860 Temsavir
Transporter inhibitor
DG02862 ABCG2 inhibitor
DG01860 Temsavir
DG02865 SLCO1B1 inhibitor
DG01860 Temsavir
DG02907 SLCO1B3 inhibitor
DG01860 Temsavir
Prodrugs [br08324.html]
DG01860
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 41
1 N5x N 6.9981 -17.4168
2 C8x C 8.2144 -18.1101
3 C8y C 9.4229 -17.4033
4 C8y C 9.4151 -16.0034
5 C8y C 8.1988 -15.3101
6 C8y C 6.9903 -16.0169
7 C8y C 10.4503 -15.0608
8 C8x C 9.8737 -13.7850
9 N4y N 8.4822 -13.9391
10 N4y N 5.7739 -15.3236
11 C8x C 5.6217 -13.9502
12 N5x N 4.2685 -13.6707
13 C8y C 3.5844 -14.8712
14 N5x N 4.5148 -15.8928
15 C1a C 2.1844 -14.8790
16 C1b C 7.4868 -12.9547
17 O2b O 7.8416 -11.6004
18 P1b P 6.8461 -10.6160
19 O1c O 7.8306 -9.6205
20 O1c O 5.8617 -11.6114
21 O1c O 5.8507 -9.6315
22 O2a O 10.6392 -18.0966
23 C1a C 10.6470 -19.4965
24 C5a C 11.8046 -15.4156
25 O5a O 12.8236 -14.3593
26 C5a C 12.5113 -16.6241
27 O5a O 11.5269 -17.6196
28 N1y N 13.8656 -16.9789
29 C1x C 14.2338 -18.3233
30 C1x C 15.5881 -18.6781
31 N1y N 16.5726 -17.6827
32 C1x C 16.2043 -16.3383
33 C1x C 14.8500 -15.9835
34 C8x C 17.3122 -20.3832
35 C8y C 18.2967 -19.3878
36 C5a C 17.9268 -18.0376
37 C8x C 17.6821 -21.7335
38 C8x C 19.0364 -22.0884
39 C8x C 20.0208 -21.0929
40 C8x C 19.6510 -19.7427
41 O5a O 18.9113 -17.0421
BOND 45
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 1
11 6 10 1
12 10 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 10 14 1
17 13 15 1
18 9 16 1
19 16 17 1
20 17 18 1
21 18 19 1
22 18 20 1
23 18 21 2
24 3 22 1
25 22 23 1
26 7 24 1
27 24 25 2
28 24 26 1
29 26 27 2
30 26 28 1
31 28 29 1
32 29 30 1
33 30 31 1
34 31 32 1
35 32 33 1
36 28 33 1
37 34 35 2
38 35 36 1
39 31 36 1
40 34 37 1
41 37 38 2
42 38 39 1
43 39 40 2
44 35 40 1
45 36 41 2
|
|---|
